NFKB1 and metabolic dysfunction-associated steatotic liver disease: Upon activation, NF-κB induces the expression of pro-inflammatory cytokines such as TNF and IL-6, initiating inflammatory and fibrotic processes central to MASLD pathogenesis [50].